Novartis India Limited (NSE:NOVARTIND)
1,050.70
+14.10 (1.36%)
May 6, 2026, 3:29 PM IST
Novartis India Revenue
Novartis India had revenue of 859.00M INR in the quarter ending December 31, 2025, a decrease of -7.63%. This brings the company's revenue in the last twelve months to 3.48B, down -1.67% year-over-year. In the fiscal year ending March 31, 2025, Novartis India had annual revenue of 3.56B with 6.33% growth.
Revenue (ttm)
3.48B
Revenue Growth
-1.67%
P/S Ratio
7.46
Revenue / Employee
62.08M
Employees
56
Market Cap
25.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.56B | 212.00M | 6.33% |
| Mar 31, 2024 | 3.35B | -436.70M | -11.53% |
| Mar 31, 2023 | 3.79B | -211.30M | -5.28% |
| Mar 31, 2022 | 4.00B | 185.20M | 4.86% |
| Mar 31, 2021 | 3.81B | -569.00M | -12.98% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 17.60B |
| Innova Captab | 14.97B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.33B |
| Ind-Swift Laboratories | 5.94B |
| Beta Drugs | 3.85B |
Novartis India News
- 2 months ago - Pharma sector stocks today, Feb 20: Novartis India rally 20%, Biocon jumps 1.36%, Alembic rises 1.11% - Business Upturn
- 2 months ago - Novartis India shares in focus today as mandatory open offer triggered after 70.68% stake deal - Business Upturn
- 2 months ago - Novartis India shares surge 14.65% today after Novartis AG to sell 70.68% stake - Business Upturn
- 1 year ago - Novartis India stock surges 9% as Alkem Labs eyes ₹2,000 crore acquisition - Business Upturn